LNRCT
Published by:
Giant Med-Rech DevelopmentLtd
Description
用于收集“人脐带间充质干细胞治疗狼疮性肾炎的随机盲态平行对照多中心研究”过程中产生的临床试验数据
Screenshots
LNRCT FAQ
-
Is LNRCT free?
Yes, LNRCT is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is LNRCT legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does LNRCT cost?
LNRCT is free.
-
What is LNRCT revenue?
To get estimated revenue of LNRCT app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
LNRCT Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
LNRCT Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
血糖管家 - 血糖記錄與血糖監測
糖尿病血糖綜合管理軟件
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
医库-医生的移动医学知识库
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
创想医生
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
掌上微试 - 让临床研究更简单
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
药研社
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
WeTrial-EDC
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
天坛功能神经外科
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
参天Spring研究
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
患者管理服务系统
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
心脏瓣膜疾病临床数据平台
|
Unlock
|
Unlock
|
0
|
|
5 months ago |
LNRCT Installs
Last 30 days
LNRCT Revenue
Last 30 daysLNRCT Revenue and Downloads
Gain valuable insights into LNRCT performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Giant Med-Rech DevelopmentLtd
- Languages
- English
- Recent release
- 1.0.0 (2 years ago )
- Released on
- Apr 29, 2022 (2 years ago )
- Also available in
- Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , New Zealand , Peru , Philippines , Pakistan , Italy , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , India
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.